Categories AlphaGraphs, Earnings, Health Care

Johnson & Johnson (JNJ) Q3 2024 Earnings: Key financials and quarterly highlights

Johnson & Johnson (NYSE: JNJ) reported its third quarter 2024 earnings results today.

Reported sales increased 5.2% year-over-year to $22.5 billion.

GAAP earnings decreased 37.5% to $2.7 billion while EPS fell 34% to $1.11 compared to last year. Adjusted EPS was down 9% to $2.42.

Revenue and earnings beat expectations.

For full-year 2024, JNJ expects reported sales of $88.4-88.8 billion and adjusted EPS of $9.88-9.98.

The stock was down 1% in premarket hours on Tuesday.

Prior performance

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

Lamb Weston (LW) Q2 2026 Earnings: Key financials and quarterly highlights

Lamb Weston Holdings, Inc. (NYSE: LW) reported its second quarter 2026 earnings results today. Net sales inched up 1% year-over-year to $1.62 billion. Net sales at constant currency remained flat.

Paychex reports higher Q2 FY26 revenue and earnings; EPS beats estimates

Paychex Inc. (NASDAQ: PAYX) on Friday reported stronger-than-expected adjusted earnings for the second quarter of fiscal 2026. Revenues grew 18% year-over-year. The Rochester-based human capital management solutions provider reported revenues

Key highlights from NIKE’s (NKE) Q2 2026 earnings results

NIKE, Inc. (NYSE: NKE) reported revenues of $12.4 billion for the second quarter of 2026, which were up 1% on a reported basis and flat on a currency-neutral basis compared

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top